George Rodgers, MD
Hematology · Salt Lake City, UTNPI 1578512190
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $82,224 of the $133,182 with a category attached, or 61.7%. It is spread thinly across 18 manufacturers, the largest accounting for just 22.1%. Reporting peaked in 2022 at $33,658 and has fallen 82.4% since, to $5,926 in 2025.
Across 99 payments — averaging $1345.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pharmacosmos Therapeutics Inc.$29K
- Sanofi$21K
- AstraZeneca$20K
- Grifols, S.A.$17K
- Dova Pharmaceuticals$16K
- Genentech USA, Inc.$7K
- plus $24K from 12 others
Across 20 payments — averaging $4344.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sobi, Inc$57K
- Pfizer$10K
- Bayer$9K
- Rigel Pharmaceuticals, Inc.$6K
- Takeda Pharmaceuticals U.S.A., Inc.$3K
- Janssen Research & Development, LLC$2K
What the payments were for
- Consulting fees$82,22462%
- Speaking & faculty fees$29,74322%
- Travel & lodging$18,11214%
- Food & beverage$3,1042%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pharmacosmos Therapeutics Inc. | 9 | $29,409 |
| Sanofi | 19 | $20,827 |
| AstraZeneca | 17 | $19,556 |
| Grifols, S.A. | 5 | $16,530 |
| Dova Pharmaceuticals | 5 | $15,736 |
| Genentech USA, Inc. | 7 | $7,371 |
| Astrazeneca AB | 2 | $6,549 |
| Sobi, Inc | 1 | $3,700 |
| Bioverativ Therapeutics Inc. | 4 | $3,540 |
| Novartis | 5 | $3,530 |
| Fresenius USA Inc. | 1 | $3,000 |
| Astrazeneca UK Limited | 10 | $2,538 |
| Octapharma USA, Inc. | 2 | $316 |
| Grifols Shared Services North America, Inc. | 2 | $187 |
| Bio Products Laboratory USA, Inc. | 1 | $131 |
| Grifols USA, LLC | 6 | $90 |
| Recordati_rare_diseases_inc. | 1 | $87 |
| Sanofi-aventis U.S. LLC | 2 | $86 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Monoferric$29,267
- DOPTELET$19,380
- Thrombate III$16,688
- HEMLIBRA$7,283
- ALPROLIX$6,112
- NO PRODUCT DISCUSSED$3,380
- PROMACTA$3,339
- QFITLIA$1,844
- ULTOMIRIS$325
- WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN)$300
- CABLIVI$262
- WAYRILZ$260
- SOLIRIS$150
- ENJAYMO$135
- Fabhalta$131
- Coagadex$131
How this compares
Too few hematology providers in Utahto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 43 | $34,472 |
| XareltoRivaroxaban | 20 | $29,274 |
| AranespDarbepoetin Alfa In Polysorbat | 11 | $11,467 |
| Enoxaparin Sodium | 23 | $6,751 |
| Cyclosporine ModifiedCyclosporine, Modified | 24 | $1,339 |
| Tranexamic Acid | 31 | $1,331 |
| Hydroxyurea | 16 | $381 |
| Dexamethasone | 13 | $164 |
| Celecoxib | 11 | $75 |
Paid to pharmacies, not to this prescriber.
Other hematology in Salt Lake City
- Deborah StephensSalt Lake City$98K
- Srinivas TantravahiSalt Lake City$81K
- Daniel ErmannSalt Lake City$74K
- Charles ParkerSalt Lake City$54K
- Jay PatelSalt Lake City$49K
- Josef PrchalSalt Lake City$48K
- Ami PatelSalt Lake City$5K
- Kristi SmockSalt Lake City$4K
- Margaret BaronSalt Lake City$524
- Archana AgarwalSalt Lake City$345
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.